Treatment of psoriasis in patients with hepatitis C virus infection.
V
V
Di Lernia
D017255:Acitretin / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects; D016572:Cyclosporine / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D011565:Psoriasis / Q000139:chemically induced*; D012254:Ribavirin / Q000009:adverse effects
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012254:Ribavirin; D016572:Cyclosporine; D017255:Acitretin; D008727:Methotrexate